[1] |
Wei LY, Kong M, Zhang Z, et al.
Breast metastasis of gastric signet-ring cell carcinoma[J]. J Zhejiang Univ Sci BJ Zhejiang Univ Sci B, 2017, 18(11): 1026-1030.
doi: 10.1631/jzus.B1700159 |
[2] |
Dulskas A, Al Bandar M, Choi YY, et al.
A case of gastric cancer metastasis to the breast in a female with BRCA2 germline mutation and literature review[J]. Acta Chir BelgActa Chir Belg, 2019, 119(1): 59-63.
doi: 10.1080/00015458.2017.1411554 |
[3] |
Kamimura K, Nagamachi S, Wakamatsu H, et al.
Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET[J]. Nucl Med CommunNucl Med Commun, 2009, 30(6): 431-439.
doi: 10.1097/MNM.0b013e3283299a2f |
[4] |
Ming Y, Wu N, Qian TY, et al. Progress and future trends in PET/CT and PET/MRI molecular imaging approaches for breast cancer[J/OL]. Front Oncol, 2020, 10: 1301[2021-08-17]. https://www.frontiersin.org/articles/10.3389/fonc.2020.01301/full. DOI: 10.3389/fonc.2020.01301. |
[5] |
Paydary K, Seraj SM, Zadeh MZ, et al.
The evolving role of FDG-PET/CT in the diagnosis, staging, and treatment of breast cancer[J]. Mol Imaging BiolMol Imaging Biol, 2019, 21(1): 1-10.
doi: 10.1007/s11307-018-1181-3 |
[6] |
胡芸, 杨帆.
炎性乳癌诊断与治疗的现状及研究进展[J]. 中国普通外科杂志中国普通外科杂志, 2019, 28(11): 1427-1436.
doi: 10.7659/j.issn.1005-6947.2019.11.017 Hu Y, Yang F. Diagnosis and treatment of inflammatory breast cancer: current status and research progress[J]. Chin J Gen SurgChin J Gen Surg, 2019, 28(11): 1427-1436. doi: 10.7659/j.issn.1005-6947.2019.11.017 |
[7] |
van Uden DJP, Prins MW, Siesling S, et al.
[18F]FDG PET/CT in the staging of inflammatory breast cancer: a systematic review[J]. Crit Rev Oncol HematolCrit Rev Oncol Hematol, 2020, 151: 102943-.
doi: 10.1016/j.critrevonc.2020.102943 |
[8] |
Bozkaya Y, Erdem GU, Ozdemir NY, et al.
Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach[J]. Curr Med Res OpinCurr Med Res Opin, 2017, 33(1): 109-116.
doi: 10.1080/03007995.2016.1239192 |
[9] |
汪洋, 朱娅, 丁洁, 等.
胃印戒细胞癌伴乳腺转移1例并文献复习[J]. 肿瘤预防与治疗肿瘤预防与治疗, 2019, 32(10): 930-934.
doi: 10.3969/j.issn.1674-0904.2019.10.012 Wang Y, Zhu Y, Ding J, et al. Breast metastasis of gastric signet-ring cell carcinoma: a case report and literature review[J]. J Cancer Control TreatJ Cancer Control Treat, 2019, 32(10): 930-934. doi: 10.3969/j.issn.1674-0904.2019.10.012 |
[10] |
贺通, 王黔, 王海斌, 等.
以左乳包块为首发症状的胃癌乳腺转移一例[J]. 中华普通外科学文献(电子版)中华普通外科学文献(电子版), 2020, 14(5): 371-372.
doi: 10.3877/cma.j.issn.1674-0793.2020.05.013 He T, Wang Q, Wang HB, et al. A case of gastric cancer with breast metastasis with left breast mass as the first symptom[J]. Chin Arch Gen Surg: Electron EdChin Arch Gen Surg: Electron Ed, 2020, 14(5): 371-372. doi: 10.3877/cma.j.issn.1674-0793.2020.05.013 |
[11] |
王雪莹, 章佳新.
胃癌乳腺转移两例报告并文献复习[J]. 中华肿瘤防治杂志中华肿瘤防治杂志, 2017, 24(6): 414-417.
doi: 10.16073/j.cnki.cjcpt.2017.06.012 Wang XY, Zhang JX. Report of two cases of breast metastasis from gastric cancer and review of the literature[J]. Chin J Cancer Prev TreatChin J Cancer Prev Treat, 2017, 24(6): 414-417. doi: 10.16073/j.cnki.cjcpt.2017.06.012 |
[12] |
Chauhan A, Sanchez-Avila M, Manivel J, et al.
Optimization of immunophenotypic panel to differentiate upper from lower gastrointestinal adenocarcinomas: analysis of new and traditional markers[J]. Appl Immunohistochem Mol MorpholAppl Immunohistochem Mol Morphol, 2021, 29(1): 13-19.
doi: 10.1097/PAI.0000000000000831 |
[13] |
刘丽杰, 梁月祥, 何冬雷.
胃转移性乳腺癌一例[J]. 临床肿瘤学杂志临床肿瘤学杂志, 2021, 26(2): 186-188.
doi: 10.3969/j.issn.1009-0460.2021.02.017 Liu LJ, Liang YX, He DL. A case of gastric metastatic breast cancer[J]. Chin Clin OncolChin Clin Oncol, 2021, 26(2): 186-188. doi: 10.3969/j.issn.1009-0460.2021.02.017 |
[14] |
Gown AM, Fulton RS, Kandalaft PL.
Markers of metastatic carcinoma of breast origin[J]. HistopathologyHistopathology, 2016, 68(1): 86-95.
doi: 10.1111/his.12877 |
[15] |
Jiang X, Wang XX, Shen TP, et al. FAPI-04 PET/CT using [18F]AlF labeling strategy: automatic synthesis, quality control, and in vivo assessment in patient[J/OL]. Front Oncol, 2021, 11: 649148[2021-08-17]. https://www.frontiersin.org/articles/10.3389/fonc.2021.649148/full. DOI: 10.3389/fonc.2021.649148. |